Pfizer LLN 100 (Lorbrena 100 mg)
Generic Name: lorlatinib
Pill with imprint Pfizer LLN 100 is Purple, Elliptical/Oval and has been identified as Lorbrena 100 mg. It is supplied by Pfizer Inc.
Lorbrena is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Lorbrena 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer LLN 100
More about Lorbrena (lorlatinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history